Precigen (PGEN) Other Non Operating Income (2012 - 2026)
Precigen (PGEN) reported Other Non Operating Income of $290000.0 for Q1 2026, up 4042.86% year-over-year from $7000.0 in Q1 2025, and up 383.33% quarter-over-quarter from $60000.0 in Q4 2025.
Precigen (PGEN) Other Non Operating Income (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Other Non Operating Income data on file, last reported at $290000.0 in Q1 2026.
- Other Non Operating Income for Q1 2026 came in at $290000.0, up 4042.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $326000.0 (down 94.14% YoY), and the FY2025 annual result was $43000.0, down 99.23% from the prior year.
- Other Non Operating Income advanced to $290000.0 in Q1 2026 per PGEN's latest filing, from $60000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $8.5 million in Q4 2024 and troughed at -$3.0 million in Q3 2024.
- A 5-year average of $476117.6 and a median of $44000.0 in 2023 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2022 and 2024: Other Non Operating Income jumped 13250.0% in 2022, then sank 1162.28% in 2024.
- A 5-year view of Other Non Operating Income shows it stood at $263000.0 in 2022, then tumbled by 129.66% to -$78000.0 in 2023, then surged by 10997.44% to $8.5 million in 2024, then sank by 99.29% to $60000.0 in 2025, then soared by 383.33% to $290000.0 in 2026.
- Business Quant data shows PGEN's Other Non Operating Income at $290000.0 in Q1 2026, $60000.0 in Q4 2025, and $7000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Precigen | 1.27 Bn | 1.27 Bn | 20.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 290,000.00 |
| Dec 31, 2025 | 60,000.00 |
| Sep 30, 2025 | 7,000.00 |
| Jun 30, 2025 | -31,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Dec 31, 2024 | 8.50 Mn |
| Sep 30, 2024 | -2.99 Mn |
| Jun 30, 2024 | 43,000.00 |
| Mar 31, 2024 | 37,000.00 |
| Dec 31, 2023 | -78,000.00 |
| Sep 30, 2023 | 281,000.00 |
| Jun 30, 2023 | 44,000.00 |
| Mar 31, 2023 | 380,000.00 |
| Dec 31, 2022 | 263,000.00 |
| Sep 30, 2022 | 1.04 Mn |
| Jun 30, 2022 | 40,000.00 |
| Mar 31, 2022 | 198,000.00 |
| Dec 31, 2021 | -2,000.00 |
| Sep 30, 2021 | -133,000.00 |
| Jun 30, 2021 | -199,000.00 |